Diploma (LON:DPLM) Stock Passes Above Two Hundred Day Moving Average - Here's Why

Shares of Diploma PLC (LON:DPLM - Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 4,870.30 ($65.07) and traded as high as GBX 5,500 ($73.48). Diploma shares last traded at GBX 5,460 ($72.95), with a volume of 1,598,339 shares trading hands.Analyst Ratings ChangesDPLM has been the subject of several analyst reports. Royal Bank Of Canada raised Diploma to an "outperform" rating and upped their price objective for the stock from GBX 4,500 to GBX 6,000 in a research report on Friday, October 3rd. Shore Capital reaffirmed a "hold" rating and issued a GBX 5,100 price objective on shares of Diploma in a research note on Thursday, July 17th. Jefferies Financial Group raised their price objective on Diploma from GBX 4,500 to GBX 5,200 and gave the stock a "hold" rating in a report on Thursday, September 11th. JPMorgan Chase & Co. restated a "neutral" rating and set a GBX 4,440 price objective on shares of Diploma in a report on Wednesday, August 6th. Finally, Berenberg Bank lifted their target price on Diploma from GBX 5,750 to GBX 6,350 and gave the company a "buy" rating in a report on Wednesday, September 10th. Three investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Diploma presently has an average rating of "Moderate Buy" and an average price target of GBX 5,365.Check Out Our Latest Stock Report on DiplomaDiploma Price PerformanceThe stock has a market cap of £7.30 billion, a PE ratio of 43.85, a PEG ratio of 2.82 and a beta of 0.75. The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17. The stock has a 50 day moving average of GBX 5,383.55 and a two-hundred day moving average of GBX 4,870.30. About Diploma (Get Free Report)Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.See AlsoFive stocks we like better than DiplomaConsumer Staples Stocks, ExplainedArcher’s Recent String of Victories Signals a New Phase of GrowthWhat is a Dividend Harvesting Strategy and How Can Investors Profit from it?3 Key Stocks Boosting Buybacks Amid Improving FundamentalsWhy Invest in 5G? How to Invest in 5G Stocks The Best AI for Picking Stocks, Ranked by PerformanceThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Diploma Right Now?Before you consider Diploma, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.While Diploma currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here